Özkurt ZN - Search Results

1

Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia.

Kaynar LA, Gökçen S, Can F, Yeğin ZA, Özkurt ZN, Yağcı M. Kaynar LA, et al. Among authors: ozkurt zn. Ann Hematol. 2022 Jul;101(7):1459-1464. doi: 10.1007/s00277-022-04835-6. Epub 2022 Apr 23. Ann Hematol. 2022. PMID: 35460388

2

Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience.

Sucak GT, Aki ZS, Yagcí M, Yegin ZA, Ozkurt ZN, Haznedar R. Sucak GT, et al. Among authors: ozkurt zn. Transplant Proc. 2007 Jun;39(5):1558-63. doi: 10.1016/j.transproceed.2007.01.075. Transplant Proc. 2007. PMID: 17580188

3

Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity.

Sucak GT, Ozkurt ZN, Aki Z, Yagci M, Cengel A, Haznedar R. Sucak GT, et al. Among authors: ozkurt zn. Transplant Proc. 2008 Jun;40(5):1586-90. doi: 10.1016/j.transproceed.2007.11.077. Transplant Proc. 2008. PMID: 18589156

4

The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?

Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Karakan T, Akyol G. Sucak GT, et al. Among authors: ozkurt zn. Bone Marrow Transplant. 2008 Oct;42(7):461-7. doi: 10.1038/bmt.2008.193. Epub 2008 Jul 7. Bone Marrow Transplant. 2008. PMID: 18604240

5

Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment.

Konca C, Özkurt ZN, Deger M, Akı Z, Yağcı M. Konca C, et al. Among authors: ozkurt zn. Int J Hematol. 2009 Jan;89(1):58-62. doi: 10.1007/s12185-008-0192-2. Epub 2008 Nov 20. Int J Hematol. 2009. PMID: 19020950

6

Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.

Aki SZ, Sucak GT, Ozkurt ZN, Yeğin ZA, Yağci M, Haznedar R. Aki SZ, et al. Among authors: ozkurt zn. Transfus Apher Sci. 2009 Feb;40(1):5-11. doi: 10.1016/j.transci.2008.11.007. Epub 2009 Jan 3. Transfus Apher Sci. 2009. PMID: 19121979

7

Thrombopoietic cytokine and P-selectin levels in patients with multiple myeloma undergoing autologous stem cell transplantation: decrease in posttransplantation P-selectin levels might predict the degree of maximum response.

Aki SZ, Sucak GT, Paşaoğlu H, Ozkurt ZN, Yegin ZA, Ofluoğlu E, Yağci M, Haznedar R. Aki SZ, et al. Among authors: ozkurt zn. Clin Lymphoma Myeloma. 2009 Jun;9(3):229-33. doi: 10.3816/CLM.2009.n.045. Clin Lymphoma Myeloma. 2009. PMID: 19525192

8

Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.

Ozkurt ZN, Sucak GT, Aki SZ, Yağci M, Erdem O. Ozkurt ZN, et al. Cutan Ocul Toxicol. 2009;28(3):141-3. doi: 10.1080/15569520903046934. Cutan Ocul Toxicol. 2009. PMID: 19548772

9

Thrombopoietic cytokines and platelet count in multiple myeloma.

Ozkurt ZN, Yağci M, Sucak GT, Kirazli S, Haznedar R. Ozkurt ZN, et al. Platelets. 2010;21(1):33-6. doi: 10.3109/09537100903360007. Platelets. 2010. PMID: 19891528

10

Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.

Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT. Ozkurt ZN, et al. Transplant Proc. 2009 Nov;41(9):3851-8. doi: 10.1016/j.transproceed.2009.06.189. Transplant Proc. 2009. PMID: 19917400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page